263 results
Page 6 of 14
6-K
EX-99.1
cku9yt me
13 Nov 19
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2020
7:55am
6-K
EX-99.1
mc9m lacpszw
7 Nov 19
Acasti Pharma Announces Publication of CaPre Pharmacokinetics Study in a Leading Peer-Reviewed Journal
8:42am
6-K
EX-99.1
utd5bqwd djos
6 Nov 19
Acasti Pharma Schedules Second Quarter Fiscal 2020 Conference Call
9:39am
6-K
EX-99.1
m3u1lo
4 Nov 19
Agreement provides Acasti long-term supply of raw krill oil through commercialization
9:24am
6-K
EX-99.1
b6doyoszdtbixtoalbo
1 Oct 19
Acasti Pharma to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
9:00am
6-K
EX-99.1
n0gp4kks2rjsqq 99
30 Sep 19
Nearly 80% of randomized patients have completed the studies
8:37am
6-K
EX-99.1
9f1p98zifv
9 Sep 19
Acasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity
8:41am
6-K
EX-99.1
c46fnu8n
4 Sep 19
Acasti Pharma to Present at the 21st Annual Rodman & Renshaw Global Investment Conference in New York City on September 9th
9:00am
6-K
EX-99.1
mao22xjfxghj 8n
28 Aug 19
Current report (foreign)
4:05pm
6-K
EX-99.1
sj2dua74
14 Aug 19
Current report (foreign)
12:00am
6-K
EX-99.1
jqrawm7iy9jd84
14 Aug 19
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2020
12:00am
6-K
EX-99.1
d4mymr9 dhbbmfvo1z
9 Aug 19
Acasti Pharma Co-Founder, Chief Operating and Scientific Officer to Participate on Lipid Panel at the 2019 BTIG Biotechnology Conference
8:00am
6-K
EX-99.1
h8fh q1inz70
7 Aug 19
Acasti Pharma Schedules First Quarter Fiscal 2020 Conference Call
8:00am
F-3
qdmrsnikc021jjaz8soe
7 Aug 19
Shelf registration (foreign)
12:00am
6-K
EX-99.1
ylgb wl31a81hn
6 Aug 19
Notice of Annual and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
4cox4pic
25 Jul 19
Current report (foreign)
3:56pm
POS AM
31shwhb 082g8cgs
15 Jul 19
Prospectus update (post-effective amendment)
5:15pm
6-K
EX-99.1
efmsuaa76q9n
26 Jun 19
Acasti Pharma Provides Fiscal 2019 Year-End Business Update
8:06am
6-K
EX-99.1
w0x05cdk5aqi
24 Jun 19
Acasti Pharma Awarded Notice of Allowance for a Second Patent in China Covering CaPre’s Omega-3 Phospholipid Composition
9:01am